Table of Content

Open Access iconOpen Access

ARTICLE

Impact of durable ventricular assist devices on post‐transplant outcomes in adults with congenital heart disease

Ari Cedars1, Luke Burchill2, S. Lucy Roche3, Jonathan Menachem4, Kelly Axsom5, Kristen Tecson6

1 University of Texas Southwestern Medical School, Dallas, Texas, USA
2 University of Melbourne, Melbourne, Australia
3 University of Toronto, Toronto, Ontario, Canada
4 Vanderbilt University, Nashville, Tennessee, USA
5 Columbia University, New York, New York, USA
6 Baylor University Medical Center, Dallas, Texas, USA

* Corresponding Author: Ari Cedars, The University of Texas Southwestern Medical Center, 2001 Inwood Rd. Suite WC05.852, Dallas, TX 75390, USA. Email: email

Congenital Heart Disease 2019, 14(6), 958-962. https://doi.org/10.1111/chd.12851

Abstract

Background: There are no published data on post‐transplant outcomes in durable ven‐ tricular assist device (VAD)‐supported adult congenital heart disease (ACHD) patients.
Methods: We compared post‐transplant outcomes in VAD‐supported vs non‐VAD‐ supported ACHD patients using the Scientific Registry of Transplant Recipients.
Results: At 1 year, there was no difference in post‐transplant mortality between VAD‐supported (12 patients) and non‐VAD‐supported (671 patients) ACHD patients.
Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

Keywords


Cite This Article

Cedars, A., Burchill, L., Roche, S. L., Menachem, J., Axsom, K. et al. (2019). Impact of durable ventricular assist devices on post‐transplant outcomes in adults with congenital heart disease. Congenital Heart Disease, 14(6), 958–962.



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1345

    View

  • 975

    Download

  • 0

    Like

Share Link